U.S., Feb. 15 -- ClinicalTrials.gov registry received information related to the study (NCT06828705) titled 'Establish the First International Database on Semi-quantitative Values Obtained in Scintigraphy With Datscan(R) in Cadmium-Zinc-Telluride Camera' on Jan. 31.
Brief Summary: Datscan scintigraphy is a nuclear medicine examination allowing the diagnosis of neurodegenerative pathologies linked to damage to dopaminergic pathways, such as Parkinson's disease (essential for the differential diagnosis of essential tremor).
Study Start Date: April 30
Study Type: OBSERVATIONAL
Condition:
Neurodegenerative Diseases
Intervention:
OTHER: datscan scintigraphy
Semi-quantitative analysis on Datscan imaging scintigraphy
Recruitment Status: N...